These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 16782916

  • 1. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
    Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS.
    J Clin Oncol; 2006 Jun 20; 24(18):2757-64. PubMed ID: 16782916
    [Abstract] [Full Text] [Related]

  • 2. Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
    Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS.
    J Clin Oncol; 2006 Jun 20; 24(18):2750-6. PubMed ID: 16782915
    [Abstract] [Full Text] [Related]

  • 3. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.
    Cancer; 2005 Jun 01; 103(11):2241-51. PubMed ID: 15844176
    [Abstract] [Full Text] [Related]

  • 4. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 Jun 01; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 5. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
    Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI.
    Breast Cancer Res Treat; 2006 Oct 01; 99(3):313-21. PubMed ID: 16583264
    [Abstract] [Full Text] [Related]

  • 6. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P, Fohlin H, Arnesson LG, Dufmats M, Nordenskjöld K, Nordenskjöld B, Stål O, South-East Sweden Breast Cancer Study Group.
    Acta Oncol; 2009 Oct 01; 48(4):504-13. PubMed ID: 19235568
    [Abstract] [Full Text] [Related]

  • 7. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
    Baxter NN, Durham SB, Phillips KA, Habermann EB, Virning BA.
    J Am Geriatr Soc; 2009 Mar 01; 57(3):403-11. PubMed ID: 19278395
    [Abstract] [Full Text] [Related]

  • 8. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.
    Cancer; 2006 Dec 01; 107(11):2581-8. PubMed ID: 17078055
    [Abstract] [Full Text] [Related]

  • 9. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy.
    Kaplan HG, Malmgren JA, Atwood M.
    Breast J; 2009 Dec 01; 15(5):454-60. PubMed ID: 19671105
    [Abstract] [Full Text] [Related]

  • 10. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714
    [Abstract] [Full Text] [Related]

  • 11. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R.
    J Clin Oncol; 2006 Feb 20; 24(6):872-7. PubMed ID: 16484696
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of radiation therapy for older women with early breast cancer.
    Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG.
    J Natl Cancer Inst; 2006 May 17; 98(10):681-90. PubMed ID: 16705122
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
    Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.
    J Clin Oncol; 2005 Dec 01; 23(34):8597-605. PubMed ID: 16314622
    [Abstract] [Full Text] [Related]

  • 15. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
    Sail KR, Franzini L, Lairson DR, Du XL.
    Value Health; 2012 Jan 01; 15(1):72-80. PubMed ID: 22264974
    [Abstract] [Full Text] [Related]

  • 16. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA, Lickley HL, Trudeau ME, Hanna WM, Kahn HJ, Murray D, Sawka CA, Mobbs BG, McCready DR, Pritchard KI.
    Breast J; 2006 Jan 01; 12(1):37-47. PubMed ID: 16409585
    [Abstract] [Full Text] [Related]

  • 17. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT, Danish Breast Cancer Cooperative Group.
    J Natl Cancer Inst; 2011 Sep 21; 103(18):1363-72. PubMed ID: 21881042
    [Abstract] [Full Text] [Related]

  • 18. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD.
    J Am Geriatr Soc; 2009 Aug 21; 57(8):1403-10. PubMed ID: 19563521
    [Abstract] [Full Text] [Related]

  • 19. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
    Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA.
    Cancer; 2006 Jun 15; 106(12):2556-62. PubMed ID: 16691617
    [Abstract] [Full Text] [Related]

  • 20. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
    Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W, Korean Breast Cancer Society.
    J Clin Oncol; 2007 Jun 10; 25(17):2360-8. PubMed ID: 17515570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.